| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011111051A1 Death associated protein 1 variants and use thereof for modulating autophagy |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224239 Combinations Comprising a S1P Receptor Agonist and a JAK3 Kinase Inhibitor |
| 09/15/2011 | US20110224177 Combinations comprising antimuscarinic agents and corticosteroids |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223259 Anti-viral pharmaceutical compositions |
| 09/15/2011 | US20110223239 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110220539 Synthesis of high molecular weight iron-saccharidic complexes |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364709A1 Antimicrobial compositions and methods of use |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP2364707A2 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 09/14/2011 | EP2364704A1 Combination of beta-adrenoceptor agonist and corticosteroid |
| 09/14/2011 | EP2364699A1 Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 09/14/2011 | EP2364154A1 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
| 09/14/2011 | EP2364151A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
| 09/14/2011 | EP2364145A1 Dosage forms for the rapid and sustained elevation of gastric ph |
| 09/14/2011 | EP2026765B1 Hyperthermic technologies and therapeutic uses thereof |
| 09/14/2011 | EP1446401B1 C5-modified indazolylpyrrolotriazines |
| 09/14/2011 | EP1445314B1 Novel glutamic acid receptor and utilization thereof |
| 09/14/2011 | EP1441766B1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | CN1695738B Composition of medication for treating high blood pressure |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1602959B Use of composition of nutrient product for enhancing immunity, preventing cancer and prolonging life of cancer patient |
| 09/14/2011 | CN102186482A Method for treating pulmonary arterial hypertension |
| 09/14/2011 | CN102186480A Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid |
| 09/14/2011 | CN102186472A Treatment |
| 09/14/2011 | CN102186470A Topical nsaid compositions having sensate component |
| 09/14/2011 | CN102183655A New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN101757629B Medicine composition for treating acute and chronic aryngitis and preparation method thereof |
| 09/14/2011 | CN101087602B Use of L-carnitine and flucose for the treatment of cardiovascular diseases |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017745 Plasmodium falciparum antigens and methods of use |
| 09/13/2011 | US8017735 Comprising one or more binding compositions comprising a member selected from a light chain amino acid sequence which comprises CDR-L1 and a heavy chain amino acid sequence which comprises CDR-H1 in association with one or more chemotherapeutic agents; cancer therapy |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017595 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/13/2011 | US8017580 Therapies for chronic renal failure |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2640451C Medicine for transnasal administration |
| 09/13/2011 | CA2628857C Formulation and method for treating neoplasms by inhalation |
| 09/13/2011 | CA2522318C Drug for preventing or treating angiogenic eye diseases |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2469075C Pyrrolidine derivatives as prostaglandin modulators |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2356637C Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2297101C Receptor specific transepithelial transport of therapeutics |
| 09/09/2011 | WO2011109294A1 Lipid delivery formulations |
| 09/09/2011 | WO2011108304A1 External preparation for skin |
| 09/09/2011 | WO2011107714A1 Cosmetic anti-ageing composition, corresponding use and application method |
| 09/09/2011 | WO2011107710A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | WO2011107653A2 Method for treating parkinson's disease |
| 09/09/2011 | WO2011107582A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 09/09/2011 | CA2791009A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | CA2790654A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 09/09/2011 | CA2784819A1 Method of treating parkinson's disease |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218253 Imaging-based identification of a neurological disease or a neurological disorder |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110217344 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/07/2011 | EP2363405A1 Anti-infarction molecules |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363397A1 Novel useful therapeutic agent for lower urinary tract symptom |
| 09/07/2011 | EP2363396A1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 09/07/2011 | EP2363149A1 Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor |
| 09/07/2011 | EP2363147A1 Composition for local anesthesia |
| 09/07/2011 | EP2363142A1 Elastase for opening obstructed biological conduits |
| 09/07/2011 | EP2363130A1 Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 09/07/2011 | EP2363125A1 Preparation for improving the sensitivity action of receptors |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 09/07/2011 | EP2363119A1 New pharmaceutical composition suitable for treating persons affected by neurodegenerative or neurovascular diseases |
| 09/07/2011 | EP2362725A1 Antiviral supplement formulations |
| 09/07/2011 | EP2101790B1 Combination comprising sapacitibine (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 09/07/2011 | EP1850851B1 Pyrrolo[2,3-d]pyrimidines for treating cancer by inhibiting mitosis |
| 09/07/2011 | EP1239862B3 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating tumor diseases |
| 09/07/2011 | CN1660433B Combination of treating and/or preventing hemorrhoid |
| 09/07/2011 | CN1660429B New application of inhibitor of matrix metal metal protease (MMP) in use for treating hemorrhoid |
| 09/07/2011 | CN1660428B New application of synthase inhibitor of nitric in use for treating hemorrhoid |
| 09/07/2011 | CN102176908A Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists |
| 09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
| 09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
| 09/07/2011 | CN102172402A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 09/07/2011 | CN102172401A Carbostyril derivatives and mood stabilizers for treating mood disorders |